Eugene Bauer has had a distinguished career in dermatology. He spent 17 years as faculty at Washington University in St. Louis before moving to Stanford to become chair of Dermatology (1988) and, later, dean at the Stanford University School of Medicine (1995). During his tenure at Stanford, he oversaw the merger of the medical centers of Stanford and the University of California-San Francisco.
He greatly enhanced molecular research at Stanford. Dr. Bauer’s research interest is Epidermolysis Bullosa (EB) and he received funding from the NIH for 24 years. In addition, he served on many advisory committees for the NIH. His laboratory is responsible for much of our current understanding of the various types of EB.
After retiring from academic medicine in 2002, he initiated a career in the pharmaceutical industry. Dr. Bauer was associated with innovative companies like Neosil, Peplin, Connetics, and Demira, several of which were bought out by major pharmaceutical houses. His efforts have resulted in clinically valuable medications that have changed the lives of innumerable dermatology patients.
Dr. Bauer completed his dermatology residency and fellowship at Washington University School of Medicine in St. Louis. He received both undergraduate and medical degrees from Northwestern University, where he and his wife established the Ruth K. Freinkel, MD, Research Professorship in Dermatology. Ten years later they established the Eugene and Gloria Bauer Professorship of Dermatology at Stanford University. Both professorships are designed to provide protected time for research for deserving faculty members.
Dr. Bauer is known for wearing frog neckties, is a student of Sherlock Holmes and admits to being a connoisseur of doughnuts in addition to having made a lasting impact on the dermatology profession.
